An expanding number of lawsuits are targeting the use of acetaminophen during pregnancy, alleging that exposure to the pain reliever in the womb raises a child’s risk for autism or attention-deficit hyperactivity disorder. Whether those cases grow and move forward—with massive financial sums at stake—could depend on a key issue before a federal judge this week: what scientific claims the plaintiffs can cite in court.